HIV Vaccine Is Now Approved!

Yeztugo is the brand name for lenacapavir, a long acting injectable developed by Gilead Sciences. It is the first and only FDA approved HIV prevention option that requires two injections per year.

This works by inhibiting the HIV capsid, a protein shell essential for viral replication that is blocking the virus at multiple stages of its life cycle.